Research ArticleOpen AccessGoogle Scholar indexed
Limphocutaneous Sporotrichosis Due to <i>Sporothrix schenckii</i> var <i>schenckii</i>: A Relapsing Case after Treatment with Potassium Iodide in Elderly
General Hospital, Mexico City, Mexico
ángeles Lomas Hospital, Mexico City, Mexico
La Habana University, Havana, Cuba
Dermatologist, General Hospital, Oaxaca, Mexico
General Hospital, Mexico City, Mexico
Pathogen Ecology Department, General Hospital, Mexico City, Mexico
General Hospital, Mexico City, Mexico
- 1 General Hospital, Mexico City, Mexico
- 2 ángeles Lomas Hospital, Mexico City, Mexico
- 3 La Habana University, Havana, Cuba
- 4 Dermatologist, General Hospital, Oaxaca, Mexico
- 5 General Hospital, Mexico City, Mexico
- 6 Pathogen Ecology Department, General Hospital, Mexico City, Mexico
- 7 General Hospital, Mexico City, Mexico
Advances in Microbiology·Volume 12 (2022)·Pages 192–197·Published 6 April 2022·DOI10.4236/aim.2022.124015
Copy link · social · email
Abstract
Sporotrichosis is a subcutaneous mycosis caused by the Sporothrix schenckii complex. It has three classic clinical variants: fixed, lymphangitic, and systemic. Treatment in most cases has been itraconazole or potassium iodide. The aim of this paper is to communicate an unusual relapsing case treated with IK. We report a 73-year-old woman with lymphangitic sporotrichosis, adequate response to treatment with potassium iodide, and recurrence 15 months after. A molecular test was performed through the amplification of a 331 bp fragment of the calmodulin gene. In both infections, the same specie was isolated. The effects of potassium iodide are briefly discussed, and we conclude that the same treatment can be prescribed, if no side effects are observed.
KeywordsSporotrichosisLymphangitic Sporotrichosis<i>Sporothrix schenckii</i>RecurrencePotassium Iodide
- Arenas, R. and Torres, E. (2019) Micologia Medica Ilustrada. 6th Edition, McGraw-Hill, New York.
- Orofino-Costa, R., de Macedo, P.M., Rodrigues, A.M. and Bernardes-Engemann, A.R. (2017) Sporotrichosis: an Update on Epidemiology, Etiopathogenesis, Laboratory, and Clinical Therapeutics. Anais Brasileiros de Dermatologia, 92, 606-620. https://doi.org/10.1590/abd1806-4841.2017279
- Rodrigues, A.M., de Hoog, G.S. and de Camargo, Z.P. (2015) Molecular Diagnosis of Pathogenic Sporothrix Species. PLOS Negl ectedTropical Diseases, 9, e0004190. https://doi.org/10.1371/journal.pntd.0004190
- Juárez-Durán, E.R., Angulo-Rodríguez, A. and Arenas, R. (2020) Antifungal Activity of Potassium Iodide: Insight in the XXI Century. ES Journal of Microbiology, 1, Article No. 1008.
- Xue, S., Gu, R., Wu, T., Zhang, M. and Wang, X. (2009) Oral Potassium Iodide for the Treatment of Sporotrichosis. Cochrane Database of Systematic Reviews, 2009, CD006136. https://doi.org/10.1002/14651858.CD006136.pub2
- Costa, R.O., de Macedo, P.M., Carvalhal, A. and Bernardes-Engemann, A.R. (2013) Use of Potassium Iodide in Dermatology: Updates on an Old Drug. Anais Brasileiros de Dermatologia, 88, 396-402. https://doi.org/10.1590/abd1806-4841.20132377
- Macedo, P.M., Lopés-Bezerra, L.M., Bernardes-Engemann, A.R., et al. (2015) New Posology of Potassium Iodide for the Treatment of Cutaneous Sporotrichosis: Study of Efficacy and Safety in 102 Patients. Journal of the European Academy of Dermatology and Venereology, 29, 719-724. https://doi.org/10.1111/jdv.12667
- Schechtman, R.C., Marinho-Falcão, E.M., Carard, M., et al. (2022) Sporotrichosis: Hyperendemic by Zoonotic Transmission, with Atypical Presentations, hypersensitivity Reactions and Greater Severity. Anais Brasileiros de Dermatologia, 97, 1-13. https://doi.org/10.1016/j.abd.2021.07.003
- Arrillaga-Moncrieff, I., Capilla, J., Mayayo, E., Marimon, R., et al. (2009) Different Virulence Levels of the Species of Sporothrix in a Murine Model. Clinical Microbiology and Infection, 15, 651-655. https://doi.org/10.1111/j.1469-0691.2009.02824.x